![](/img/cover-not-exists.png)
Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study
Shore, Neal D, Chowdhury, Simon, Villers, Arnauld, Klotz, Laurence, Siemens, D Robert, Phung, De, van Os, Steve, Hasabou, Nahla, Wang, Fong, Bhattacharya, Suman, Heidenreich, AxelLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(15)00518-5
Date:
January, 2016
File:
PDF, 595 KB
english, 2016